Skip to main content
. 2023 Apr 7;14:1144550. doi: 10.3389/fphar.2023.1144550

TABLE 2.

Anthropometric indices, dietary intake and physical activity of the patients at baseline.

OEA (n = 30) Placebo (n = 30) p
Weight (kg) 87.32 (13.79) 85.93 (14.77) 0.720 a
BMI (kg/m2) 33.79 (6.69) 35.53 (7.12) 0.335 a
Energy (kcal) 2351.17 (514.61) 2287.39 (429.11) 0.614 a
Carbohydrate (g) 313.58 (98.75) 327.12 (111.51) 0.632 a
Protein (g) 72.14 (28.17) 69.91 (24.57) 0.756 a
Total fat (g) 91.28 (36.79) 87.33 (34.12) 0.680 a
Cholesterol (mg) 153.77 (97.14, 391.67) 139.67 (94.33, 318.77) 0.501 b
SFA (g) 13.46 (7.79, 19.65) 14.70 (9.65, 18.49) 0.389 b
MUFA (g) 14.95 (6.13) 16.11 (7.03) 0.505 a
PUFA (g) 27.66 (16.95, 39.55) 23.91 (10.16, 31.33) 0.485 b
Dietary fiber (g) 15.15 (7.41, 19.74) 17.79 (5.51, 21.66) 0.335 b
Physical activity (METs) 887.78 (456.50, 1953.33) 845.11 (234.19, 1789.11) 0.715 b

BMI, body mass index; MD, METs, metabolic equivalents (MET-minutes/week); MUFA, monounsaturated fatty acids; OEA, oleoylethanolamide; PUFA, poly unsaturated fatty acids; SFA, saturated fatty acids. Mean (standard deviation) are presented for normally distributed data. Median (25th and 75th percentiles) are presented for data not normally distributed.

a

p-value based on Independent sample t-test.

b

p-value based on Mann-Whitney U test.

p < 0.05 is statistically significant.